Serum Levels of Soluble Interleukin-2 Receptor in Patients with Systemic Lupus Erythematosus and Systemic Idiopathic Vasculitis

References

• Tsokos G C, et al. Symposium in writing: Systemic Lupus Erythematosus. Clin Immunol Immunopathol 1992; 63: 3
   PubMedGoogle Scholar
• Vitali C, Bencivelli W, Bombardieri S. Disease activity measurement in Systemic Lupus Erythematosus. The state of the art. Seminars Clin Immunol 1991; 3: 15–20
   Google Scholar
• Rubin L A, Nelson D L. The soluble Interleukin-2 Receptor: biology, function and clinical application. Ann Intern Med 1990; 113: 619–27
   PubMed Web of Science ®Google Scholar
• Rosen S. The Multichain Interleukin 2 Receptor. JAMA 1990; 263: 272–4
   PubMedGoogle Scholar
• Tan E N, Cohen A S, Fries J F, et al. The 1982 revised criteria for the classification of Systemic Lupus Erythematosus. Arthritis Rheum 1982; 25: 1271–7
   PubMed Web of Science ®Google Scholar
• Coons A H. The beginnings of immunofluorescence. J Immunol 1961; 87: 499–505
   PubMedGoogle Scholar
• Carr R I, Hoffmann A E, Harbeck R J. Comparison of DNA binding in normal population, general hospital laboratory personnel and personnel from laboratories studiyng SLE. J Rheumatol 1975; 2: 178–82
   PubMedGoogle Scholar
• Sequi J, Leigh I, Isenberg D A. Relation between antinuclear antibodies and the autoimmune rheumatic diseases and disease type and activity in SLE using a variety of cultured cell lines. Ann Rheum Dis 1991; 50: 167–72
   PubMedGoogle Scholar
• Galen R S, Gambino S R. Beyond normality. John Wiley Son's, New York 1975
   Google Scholar
• Gardner M I, Altman D G. Confidence intervals rather than P values: estimation rather than hypothesis testing. Br Med J 1986; 292: 74650
   Google Scholar
• ter Borg E J, Horst G, Hummel E J, et al. Measurement of increase in anti-double-stranded DNA antibody levels as a predictor of disease exacerbation in SLE. Arthritis Rheum 1990; 33: 634–43
   PubMed Web of Science ®Google Scholar
• Munves E F, Schurp P H. Antibodies to Sm and RNP: prognosticators of disease involvement. Arthritis Rheum 1983; 26: 848–53
   PubMedGoogle Scholar
• Swaak A JG, Groenwold J, Bronsveld W. Predictive value of complement profiles and anti-ds DNA in systemic erythematosus lupus. Ann Rheum Dis 1986; 45: 359–66
   PubMed Web of Science ®Google Scholar
• Wolf R E, Brelsford W G. Soluble Interleukin-2 Receptor in systemic erythematosus lupus. Arthritis Rheum 1988; 31: 729–35
   PubMed Web of Science ®Google Scholar
• Campen D H, Horwitz D A, Quismorio F P, Jr, et al. Serum levels of Soluble Interleukin-2 Receptor and activity of rheumatic diseases characterized by immune system activation. Arthritis Rheum 1988; 31: 1358–64
   PubMed Web of Science ®Google Scholar
• Wong K L, Wong R PO. Serum soluble interleukin 2 receptor in Systemic Lupus Erythematosus: effects of disease activity and infection. Ann Rheum Dis 1991; 50: 706–9
   PubMed Web of Science ®Google Scholar
• ter Borg E J, Horst G, Limburg P C, et al. Changes in plasma levels of IL-2 receptor in relation to disease exacerbations and levels of anti-dsDNA and complement in SLE. Clin Exp Immunol 1990; 82: 21–6
   PubMed Web of Science ®Google Scholar
• Robb J R, Munck R A, Smith K A. T cell growth factor receptors: quantitation, specificity and biological relevance. J Exp Med 1991; 154: 1455–74
   Google Scholar
• Mingari M C, Gerosa F, Carra G, et al. Human IL-2 promotes proliferation of activated B cells via surface receptors similar to those of activated T cells. Nature 1984; 312: 641–3
   PubMed Web of Science ®Google Scholar
• Holter W, Grunow R, Stockinger H, et al. Recombinant intereferon-y induces IL-2 receptor on human peripheral blood lymphocytes. J Immunol 1986; 136: 2171–5
   PubMedGoogle Scholar
• Saiki O, Tanaka T, Kishimoto S. Defective expression of p70/75 IL-2 receptor in T cells from patients with SLE: a possible defect in the process of increased intracellular calcium leading to p70/75 expression. J Rheumatol 1990; 17: 1303–7
   PubMedGoogle Scholar
• Warrington R J, Sander P J, Homik J, et al. Reversible IL-2 response defects in SLE. Clin Exp lmmunol 1989; 77: 163–7
   PubMed Web of Science ®Google Scholar
• Balderas R S, Josinovic A O, Diamantstein P, et al. Elevated titers of cell-free IL-2 receptor in serum of lupus mice. J Imrnunol 1987; 139: 1496–500
   PubMedGoogle Scholar